Dauch Corp (DCH) Stock Price & Analysis
Dauch Corp (DCH) fell 4.05% to USD 6.05 as of June 10, 2026 at 15:06 UTC, according to Nexqual real-time market data.
DCH last closed at USD 6.3; the session ranged USD 6.04–6.28 on volume of 1,044,497 shares. Market capitalization is $1.43B, with a 52-week range of USD 3.94–9.25 (NYQ). Source: Nexqual, June 10, 2026 at 15:06 UTC.
Key Statistics (as of June 10, 2026 at 15:06 UTC)
| Price | USD 6.05 |
|---|---|
| Change | ▼ 4.05% (down) |
| Previous Close | USD 6.3 |
| Open | USD 6.24 |
| Day Range | USD 6.04 – 6.28 |
| 52-Week Range | USD 3.94 – 9.25 |
| Volume | 1,044,497 shares |
| Market Cap | $1.43B |
| Exchange | NYQ |
Technical Analysis (DCH)
Nexqual's technical model rates DCH "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of June 10, 2026 at 15:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.92 (neutral) |
| vs SMA50 | Below (USD 6.11) |
| MACD | 0.05 (positive) |
Analyst Ratings (DCH)
Wall Street analysts rate DCH "Buy" based on 10 analysts, with a mean price target of USD 9.28 (range USD 7–17), per Nexqual as of June 10, 2026 at 15:06 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 9.28 |
| High Target | USD 17 |
| Low Target | USD 7 |
| Buy / Hold / Sell | 6 / 5 / 0 |
Earnings (DCH)
| Next Earnings Date | 2026-05-08 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $2.80B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.34 vs est -0.03 ▲ beat |
| 2025-12-31 | USD 0.07 vs est -0.02 ▲ beat |
| 2025-09-30 | USD 0.16 vs est 0.12 ▲ beat |
| 2025-06-30 | USD 0.21 vs est 0.14 ▲ beat |
Source: Nexqual, June 10, 2026 at 15:06 UTC.
Financials & Fundamentals (DCH)
| Total Revenue | $6.80B |
|---|---|
| Revenue Growth (YoY) | +68.60% |
| Gross Margin | +11.67% |
| Operating Margin | +4.14% |
| Profit Margin | -1.87% |
| ROE | -12.08% |
| Debt / Equity | 355.27 |
| Current Ratio | 1.4 |
| Total Cash | $1.01B |
| Total Debt | $5.34B |
| Free Cash Flow | $468.60M |
Source: Nexqual, June 10, 2026 at 15:06 UTC.
Financial Health Score (DCH)
Nexqual rates Dauch Corp's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 15:06 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 12%, operating 4% |
| Balance Sheet | Critical — $1.01B cash vs $5.34B debt |
| Cash Flow | Solid — FCF $469M, 8% margin |
| Efficiency | Critical — ROE -12%, ROA 2.0% |
Ownership (DCH)
| Insider Ownership | +2.60% |
|---|---|
| Institutional Ownership | +112.67% |
| Shares Outstanding | 237.37M |
| Float | 233.00M |
| Short % of Float | +11.12% |
Source: Nexqual, June 10, 2026 at 15:06 UTC.
Leadership (DCH)
Dauch Corp is led by David Charles Dauch (age 60), Chairman & CEO, per Nexqual as of June 10, 2026 at 15:06 UTC.
| Chairman & CEO | David Charles Dauch (age 60) |
|---|---|
| Executive VP & CFO | Christopher John May (age 55) |
| President of Driveline | Michael Joseph Lynch (age 61) |
| Vice President of Marketing & Communications | Christopher M. Son |
Major Backers & Investors (DCH)
Notable institutional backers of Dauch Corp include FMR, LLC, Goldman Sachs, Bank of America Corporation, according to Nexqual as of June 10, 2026 at 15:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 4.28% |
| Goldman Sachs | 3.89% |
| Bank of America Corporation | 3.57% |
| Fidelity | 3% |
| DME Capital Management, LP | 2.66% |
| Charles Schwab Investment Management, Inc. | 2.43% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.75% |
| Vanguard Group | 8.32% |
| State Street | 4.71% |
| Dimensional Fund Advisors | 3.26% |
Source: Nexqual, June 10, 2026 at 15:06 UTC.
From Dauch Corp's Latest SEC 10-K Filing (filed 2026-02-13)
Key Strengths & Strategy (as disclosed to the SEC)
- Competition   We compete with a variety of independent suppliers and distributors, as well as with the in-house operations of certain vertically integrated OEMs.
- We have developed advanced forging and machining process technologies to manufacture lightweight, highly precise and power-dense products.
- Bringing the Future Faster • The Company's Advanced Technology Development Center (ATDC) at our Detroit campus, allows us to accelerate technological advancements.
- Most raw materials (such as steel) and semi-processed or finished items are available within the geographical regions of our operating facilities from qualified sources in quantities sufficient for our needs. We currently have contracts with our steel suppliers that help to ensure continuity of supply to our principal operating facilities. We also have validation and testing capabilities that enable us to strategically qualify steel sources on a global basis.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MHTX | Manhattan Scientifics, Inc. | USD 0 | ▲ 0% |
| AVA | Avista Corporation | USD 42.44 | ▲ 1.05% |
| BFH | Bread Financial Holdings, Inc. | USD 97.67 | ▲ 6.83% |
| IDA | IDACORP, Inc. | USD 141.5 | ▲ 2.48% |
| KSPI | Joint Stock Company Kaspi.kz - | USD 78.66 | ▼ 1.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 15:06 UTC. This page is informational and not investment advice.